Engineering Chameleon Prodrug Nanovesicles to Increase Antigen Presentation and Inhibit PD‐L1 Expression for Circumventing Immune Resistance of Cancer
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Engineering Chameleon Prodrug Nanovesicles to Increase Antigen Presentation and Inhibit PD‐L1 Expression for Circumventing Immune Resistance of Cancer
Authors
Keywords
-
Journal
ADVANCED MATERIALS
Volume -, Issue -, Pages 2102668
Publisher
Wiley
Online
2021-08-31
DOI
10.1002/adma.202102668
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- From Design to Clinic: Engineered Nanobiomaterials for Immune Normalization Therapy of Cancer
- (2021) Madiha Saeed et al. ADVANCED MATERIALS
- Engineering Stimuli‐Activatable Boolean Logic Prodrug Nanoparticles for Combination Cancer Immunotherapy
- (2020) Bo Hou et al. ADVANCED MATERIALS
- Engineering nanomedicines through boosting immunogenic cell death for improved cancer immunotherapy
- (2020) Jing Gao et al. ACTA PHARMACOLOGICA SINICA
- Autophagy promotes immune evasion of pancreatic cancer by degrading MHC-I
- (2020) Keisuke Yamamoto et al. NATURE
- Development of a pH-responsive polymersome inducing endoplasmic reticulum stress and autophagy blockade
- (2020) Funeng Xu et al. Science Advances
- Engineering Prodrug Nanomedicine for Cancer Immunotherapy
- (2020) Bin Yang et al. Advanced Science
- Overcoming immune resistance by sequential prodrug nanovesicles for promoting chemoimmunotherapy of cancer
- (2020) Fengqi Zhou et al. Nano Today
- Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
- (2019) Jérôme Galon et al. NATURE REVIEWS DRUG DISCOVERY
- Nanoengineered Immune Niches for Reprogramming the Immunosuppressive Tumor Microenvironment and Enhancing Cancer Immunotherapy
- (2019) Hathaichanok Phuengkham et al. ADVANCED MATERIALS
- Tumor Microenvironment-Activatable Prodrug Vesicles for Nanoenabled Cancer Chemoimmunotherapy Combining Immunogenic Cell Death Induction and CD47 Blockade
- (2019) Fangyuan Zhou et al. ADVANCED MATERIALS
- Near‐Infrared‐II Molecular Dyes for Cancer Imaging and Surgery
- (2019) Shoujun Zhu et al. ADVANCED MATERIALS
- Engineering nanoparticles to locally activate T cells in the tumor microenvironment
- (2019) Dangge Wang et al. Science Immunology
- Sheddable Prodrug Vesicles Combating Adaptive Immune Resistance for Improved Photodynamic Immunotherapy of Cancer
- (2019) Ang Gao et al. NANO LETTERS
- An Efficient 1064 nm NIR-II Excitation Fluorescent Molecular Dye for Deep-Tissue High-Resolution Dynamic Bioimaging
- (2018) Benhao Li et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Chemotherapy induces enrichment of CD47+/CD73+/PDL1+immune evasive triple-negative breast cancer cells
- (2018) Debangshu Samanta et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A cancer vaccine-mediated postoperative immunotherapy for recurrent and metastatic tumors
- (2018) Tingting Wang et al. Nature Communications
- A bright organic NIR-II nanofluorophore for three-dimensional imaging into biological tissues
- (2018) Hao Wan et al. Nature Communications
- Translational control of tumor immune escape via the eIF4F–STAT1–PD-L1 axis in melanoma
- (2018) Michaël Cerezo et al. NATURE MEDICINE
- Cancer immunoediting and resistance to T cell-based immunotherapy
- (2018) Jake S. O’Donnell et al. Nature Reviews Clinical Oncology
- Acidity-Triggered Ligand-Presenting Nanoparticles To Overcome Sequential Drug Delivery Barriers to Tumors
- (2017) Tingting Wang et al. NANO LETTERS
- BET-Bromodomain Inhibitors Engage the Host Immune System and Regulate Expression of the Immune Checkpoint Ligand PD-L1
- (2017) Simon J. Hogg et al. Cell Reports
- Interferon Receptor Signaling Pathways Regulating PD-L1 and PD-L2 Expression
- (2017) Angel Garcia-Diaz et al. Cell Reports
- Blocking autophagy improves the anti-tumor activity of afatinib in lung adenocarcinoma with activating EGFR mutations in vitro and in vivo
- (2017) Xiangxiang Hu et al. Scientific Reports
- Cdk5 disruption attenuates tumor PD-L1 expression and promotes antitumor immunity
- (2016) R. D. Dorand et al. SCIENCE
- BET Bromodomain Inhibition Promotes Anti-tumor Immunity by Suppressing PD-L1 Expression
- (2016) Hengrui Zhu et al. Cell Reports
- Autophagy and autophagy-related proteins in the immune system
- (2015) Shusaku T Shibutani et al. NATURE IMMUNOLOGY
- A small-molecule dye for NIR-II imaging
- (2015) Alexander L. Antaris et al. NATURE MATERIALS
- Using tumour phylogenetics to identify the roots of metastasis in humans
- (2015) Kamila Naxerova et al. Nature Reviews Clinical Oncology
- Autophagy suppresses progression of K-ras-induced lung tumors to oncocytomas and maintains lipid homeostasis
- (2013) J. Y. Guo et al. GENES & DEVELOPMENT
- Tumor metastasis: moving new biological insights into the clinic
- (2013) Liling Wan et al. NATURE MEDICINE
- Autophagy modulation as a potential therapeutic target for diverse diseases
- (2012) David C. Rubinsztein et al. NATURE REVIEWS DRUG DISCOVERY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now